Skip to main content

Diabetes Therapy

Ausgabe 3/2017

Inhalt (19 Artikel)

Open Access Review

A Practical Review of C-Peptide Testing in Diabetes

Emma Leighton, Christopher AR Sainsbury, Gregory C. Jones

Open Access Review

A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach

Sverre Christian Christiansen, Anders Lyngvi Fougner, Øyvind Stavdahl, Konstanze Kölle, Reinold Ellingsen, Sven Magnus Carlsen

Open Access Original Research

Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK

Gabriela Vega-Hernandez, Radek Wojcik, Max Schlueter

Open Access Original Research

IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting

Barnaby Hunt, Michelle Mocarski, William J. Valentine, Jakob Langer

Open Access Original Research

Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus® Insulin Glargine

Liza L. Ilag, Timothy M. Costigan, Mark A. Deeg, Robyn K. Pollom, Curtis L. Chang, Robert J. Konrad, Melvin J. Prince

Open Access Original Research

Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study

Zhou Zhou, Paresh Chaudhari, Hongbo Yang, Anna P. Fang, Jing Zhao, Ernest H. Law, Eric Q. Wu, Ruixuan Jiang, Raafat Seifeldin

Open Access Original Research

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

Thomas Haak, Hélène Hanaire, Ramzi Ajjan, Norbert Hermanns, Jean-Pierre Riveline, Gerry Rayman

Open Access Original Research

Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

Mikaela Sjöstrand, Cheryl Wei, William Cook, Kristina Johnsson, Pia S. Pollack, Christina Stahre, Boaz Hirshberg

Open Access Original Research

The Impact of Frequency and Tone of Parent–Youth Communication on Type 1 Diabetes Management

Mark D. DeBoer, Rupa Valdez, Daniel R. Chernavvsky, Monica Grover, Christine Burt Solorzano, Kirabo Herbert, Stephen Patek

Open Access Original Research

Indian Injection Technique Study: Population Characteristics and Injection Practices

Sanjay Kalra, Ambrish Mithal, Rakesh Sahay, Mathew John, A. G. Unnikrishnan, Banshi Saboo, Sujoy Ghosh, Debmalya Sanyal, Laurence J. Hirsch, Vandita Gupta, Kenneth W. Strauss

Open Access Original Research

Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional

Sanjay Kalra, Ambrish Mithal, Rakesh Sahay, Mathew John, A. G. Unnikrishnan, Banshi Saboo, Sujoy Ghosh, Debmalya Sanyal, Laurence J. Hirsch, Vandita Gupta, Kenneth W. Strauss

Open Access Brief Report

Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program

Kamlesh Khunti, Viswanathan Mohan, Sunil M. Jain, Trine Welløv Boesgaard, Kamilla Begtrup, Bipin Sethi

Open Access Brief Report

Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients

Jürgen Harreiter, Lana Kosi-Trebotic, Albert Lukas, Peter Wolf, Yvonne Winhofer, Anton Luger, Alexandra Kautzky-Willer, Michael R. Krebs

Open Access Brief Report

The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis

Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, Hidenori Yoshii, Masahiko Gosho, Hitoshi Ishii, Iichiro Shimomura, Hirotaka Watada

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.